1. Home
  2. HEQ vs PMN Comparison

HEQ vs PMN Comparison

Compare HEQ & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John Hancock Hedged Equity & Income Fund of Beneficial Interest

HEQ

John Hancock Hedged Equity & Income Fund of Beneficial Interest

HOLD

Current Price

$11.52

Market Cap

138.4M

Sector

Finance

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$11.09

Market Cap

115.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HEQ
PMN
Founded
N/A
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Investment Managers
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
138.4M
115.5M
IPO Year
2010
2022

Fundamental Metrics

Financial Performance
Metric
HEQ
PMN
Price
$11.52
$11.09
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$42.67
AVG Volume (30 Days)
44.0K
39.2K
Earning Date
01-01-0001
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.36
$0.29
52 Week High
$11.72
$27.40

Technical Indicators

Market Signals
Indicator
HEQ
PMN
Relative Strength Index (RSI) 58.93 37.47
Support Level $10.55 $10.55
Resistance Level $11.65 $13.80
Average True Range (ATR) 0.19 0.84
MACD 0.01 0.18
Stochastic Oscillator 66.13 16.72

Price Performance

Historical Comparison
HEQ
PMN

About HEQ John Hancock Hedged Equity & Income Fund of Beneficial Interest

John Hancock Hedged Equity & Income Fund is a closed-end management investment company. Its investment objective is to provide total return, with a focus on current income and gains, and to include long-term capital appreciation. It invests in various sectors such as financials, consumer discretionary, information technology, energy, healthcare, materials, real estate, consumer staples, short-term investments, and others.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: